General provisions

This course replaces and corrresponds to the sub-courses Applied therapeutics and disease states and Applied clinical pharmacokinetics and pharmacodynamics within the course 3FB005 Master's programme with breadth in clinical pharmacy.

This course replaces and corrresponds to 3FB502, applied Pharmacotherapy, Pharmacokinetics and Therapeutics.

Entry requirements

Admitted to the master's programme in clinical pharmacy.

Learning outcomes

After completing the course students will be able to:

- Describe the underlying pathophysiology, epidemiology, diagnosis, and complications of the therapeutic areas covered in the course.

- Explain the mechanisms of action, pharmacokinetic and pharmacodynamic principles and properties of the drugs included in the course, discuss the differences between the various drugs regarding these issues and explain and evaluate interactions.

- Select a dosing strategy for special patient groups and individual patients by performing pharmacokinetic and farmakodynamic calculations.

- Explain and discuss evidence-based treatment strategies and recommendations for the therapeutic areas covered in the course.

- Explain and discuss drug-related problems associated with the therapeutic areas and drugs included in the course.

- Select drug and dosing strategy according to evidence- based medicine (EBM ) and pharmacokinetic and pharmacodynamic principles to an individual patient as well as motivate and justify this on the basis of EBM and by the patient's conditions .

- Establish treatment goals and plan for initiation and withdrawal of drugs in an individual patient and motivate based on the patient's condition and the drug properties.

- Perform a medication rewiev in an individual patient by identifying and evaluating drug -related problems, set treatment goals and select and justify actions to solve the problems.

Content

The course includes disease areas according to current course description and treatment strategies and pharmacokinetic and pharmacodynamic principles necessary for monitoring and optimisation of the pharmacotherapy for the individual patient. The student works with and discusses real and complex patient cases with a focus on treatment options, drug-related problems and interventions for these.

Instruction

The teaching is given as lectures, workshops, written and oral presentations and seminars. Certain parts of the teaching are web-based. Some parts may be given in English. Compulsory parts of the course: Course introduction, workshops, seminars, written and oral presentations of assignments.

Assessment

Examination takes place (continuously) during the course and at the end of the course. For a passing grade the student must pass the examination (examination code) and all portions of the course that are obligatory (examination code). Obligatory portions of the course may be completed or re-taken when the same course is offered, if, and only if, the course is not full. Students who have failed the first examination are allowed five re-examinations.